Vanves, France

Martine Jandrot-Perrus

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Paris Cedex, FR (2013)
  • Paris, FR (2015 - 2018)
  • Vanves, FR (2006 - 2023)

Company Filing History:


Years Active: 2006-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Martine Jandrot-Perrus: Innovator in Medical Research

Introduction

Martine Jandrot-Perrus is a prominent inventor based in Vanves, France. She has made significant contributions to the field of medical research, particularly in the area of platelet aggregation and related conditions. With a total of 8 patents to her name, her work has had a substantial impact on the medical community.

Latest Patents

Among her latest patents is the invention titled "Inhibition of platelet aggregation using anti-human GPVI antibodies." This invention relates to an isolated humanized protein that binds to human Glycoprotein VI (hGPVI) for treating GPVI-related conditions. The isolated humanized protein is designed to be administered to subjects for a duration of at least 2 hours, preferably between 4 to 6 hours. Another notable patent is "Anti-human GPVI antibodies and uses thereof," which focuses on humanized anti-human GPVI antibodies and their applications.

Career Highlights

Martine has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Acticor Biotech. Her career reflects a commitment to advancing medical science and improving patient outcomes through innovative research.

Collaborations

Throughout her career, Martine has collaborated with notable professionals in her field, including Philippe Billiald and Julien Muzard. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Martine Jandrot-Perrus stands out as a leading figure in medical innovation, with her patents paving the way for advancements in the treatment of platelet-related conditions. Her dedication to research and collaboration continues to inspire future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…